Cargando…

Evaluation of radiation dose reduction in head CT using the half-dose method

PURPOSE: The present study introduced the half-dose method (HDM), which halves the radiation dose for conventional head computed tomography (CT), for postoperative hydrocephalus and follow-up for craniosynostosis at a children’s hospital. This study aimed to evaluate the contribution of selective he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakai, Yoshitomo, Miyazaki, Osamu, Kitamura, Masayuki, Imai, Rumi, Okamoto, Reiko, Tsutsumi, Yoshiyuki, Miyasaka, Mikiko, Ogiwara, Hideki, Miura, Hiroshi, Yamada, Kei, Nosaka, Shunsuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366020/ https://www.ncbi.nlm.nih.gov/pubmed/36961648 http://dx.doi.org/10.1007/s11604-023-01410-5

Ejemplares similares

Predisposing conditions for bacterial meningitis in children: what radiologists need to know
por: Masuoka, Sota, et al.
Publicado: (2021)

“Another inchworm sign” on dynamic contrast-enhanced magnetic resonance imaging in pediatric patients with cystitis cystica and glandularis: Radiologic-pathologic correlation
por: Masuoka, Sota, et al.
Publicado: (2022)

Tramadol half life is dose dependent in overdose
por: Khosrojerdi, Hamid, et al.
Publicado: (2015)

FRI683 Every Dose Counts: Response To Half The Recommended Dose Of Romosozumab
por: Ramchandani, Bhanvi Prakash, et al.
Publicado: (2023)

Half-Fluence, Half-Dose Photodynamic Therapy: Less Direct Damage but More Inflammation?
por: Desmettre, Thomas, et al.
Publicado: (2023)

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
por: Fujita, Kyoko, et al.
Publicado: (2012)

Divided method of intercostal nerve block reduces ropivacaine dose by half in thoracoscopic pulmonary resection while maintaining the postoperative pain score and 4-h mobilization: a retrospective study
por: Nakai, Aiko, et al.
Publicado: (2023)

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
por: Servillo, Andrea, et al.
Publicado: (2023)

Half-Dose versus Single-Dose Gadobutrol for Extracellular Volume Measurements in Cardiac Magnetic Resonance
por: Doeblin, Patrick, et al.
Publicado: (2023)

Correction to: Divided method of intercostal nerve block reduces ropivacaine dose by half in thoracoscopic pulmonary resection while maintaining the postoperative pain score and 4-h mobilization: a retrospective study
por: Nakai, Aiko, et al.
Publicado: (2023)

Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
por: Naseripour, Masood, et al.
Publicado: (2016)

Half-dose thrombolytic therapy in patients with right heart thrombi
por: Moosavi, Jamal, et al.
Publicado: (2019)

Low‐dose gemcitabine plus nab‐paclitaxel versus standard‐dose gemcitabine plus nab‐paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial
por: Kamata, Ken, et al.
Publicado: (2023)

Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
por: Kinoshita, Takamasa, et al.
Publicado: (2016)

Effects of half-dose and full-dose GnRH antagonists on IVF-ET outcomes: a retrospective study
por: Zhao, Yingge, et al.
Publicado: (2021)

Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
por: Li, Yebei, et al.
Publicado: (2021)

Half-dose ocrelizumab in selected patients with relapsing–remitting multiple sclerosis
por: Algahtani, Hussein, et al.
Publicado: (2023)

Use of a deep learning algorithm for non-mass enhancement on breast MRI: comparison with radiologists’ interpretations at various levels
por: Goto, Mariko, et al.
Publicado: (2023)

Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
por: Fujita, Kyoko, et al.
Publicado: (2020)

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon, Mansing, et al.
Publicado: (2013)

Half Dose Once-Daily Pemafibrate Effectively Improved Hypertriglyceridemia in Real Practice
por: Iitake, Chie, et al.
Publicado: (2019)

Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?
por: van Donge, Tamara, et al.
Publicado: (2023)

＜Editors’ Choice＞ Clinical impact of standardized creatinine on dose adjustment of capecitabine
por: Ito, Ayaka, et al.
Publicado: (2022)

Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease
por: Ehsani Ardakani, Mohammad Javad, et al.
Publicado: (2014)

Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China
por: Li, Kun-Peng, et al.
Publicado: (2018)

The effectiveness and safety of full-dose versus half-dose corticosteroid plus renin-angiotensin system blockers for IgA nephropathy
por: Wang, Li, et al.
Publicado: (2019)

One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
por: Pichai, Jirarattanasopa, et al.
Publicado: (2021)

What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness
por: Sekiguchi, Naohiro, et al.
Publicado: (2019)

Four-dimensional quantitative analysis using FDG-PET in clinical oncology
por: Tamaki, Nagara, et al.
Publicado: (2023)

Clinical outcome of one-third–dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation
por: Li, Yu, et al.
Publicado: (2012)

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak, Thuss, et al.
Publicado: (2015)

Remarkable response of recurrent endometrial adenocarcinoma to daily oral administration of half-dose etoposide
por: Nakamura, Yasuhiko, et al.
Publicado: (2018)

Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
por: Alovisi, Camilla, et al.
Publicado: (2020)

Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment
por: Inoda, Satoru, et al.
Publicado: (2019)

Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma
por: Pérez-González, David, et al.
Publicado: (2022)

Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination
por: Oka, Akihiro, et al.
Publicado: (2022)

Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy
por: Matsugasumi, Toru, et al.
Publicado: (2021)

Average Models and 3-dimensional Growth Patterns of the Healthy Infant Cranium
por: Kuwahara, Kosuke, et al.
Publicado: (2020)

Long‐term outcomes of high dose carbon‐ion radiation therapy for unresectable upper cervical (C1‐2) chordoma
por: Aoki, Shuri, et al.
Publicado: (2022)

External Doses Available for Epidemiological Studies Related to the Fukushima Health Management Survey: First 4-month Individual Doses and Municipality-average Doses for the First Year
por: Ishikawa, Tetsuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ig4dq346qtk15bv2k6g0sqivf5